▶ 調査レポート

インフルエンザ薬の世界市場2020年:メーカー別、地域別、種類・用途別

• 英文タイトル:Global Influenza Medication Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。インフルエンザ薬の世界市場2020年:メーカー別、地域別、種類・用途別 / Global Influenza Medication Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 / D0GIR-06809資料のイメージです。• レポートコード:D0GIR-06809
• 出版社/出版日:GlobalInfoResearch / 2020年9月23日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、101ページ
• 納品方法:Eメール
• 産業分類:医療、製薬、バイオ
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、インフルエンザ薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。インフルエンザ薬の種類別市場規模(ザナミビル、オセルタミビル、ペラミビル、アマンタジン、リマンタジン、イノシン、その他)、用途別市場規模(病院、クリニック、薬局、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):Daiichi Sankyo Company、Mylan、F. Hoffmann-La Roche、GlaxoSmithKline、Sun Pharmaceutical Industries、Natco Pharma、Sandoz International GmbH (Novartis AG)、Teva Pharmaceutical
・地域別グローバル市場分析 2015年-2020年
・インフルエンザ薬の北米市場(アメリカ、カナダ、メキシコ)
・インフルエンザ薬のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・インフルエンザ薬のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・インフルエンザ薬の南米市場(ブラジル、アルゼンチン)
・インフルエンザ薬の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:ザナミビル、オセルタミビル、ペラミビル、アマンタジン、リマンタジン、イノシン、その他
・用途別分析:病院、クリニック、薬局、その他
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論

Market Overview
The global Influenza Medication market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.7% in the forecast period of 2020 to 2025 and will expected to reach USD 654.9 million by 2025, from USD 545.7 million in 2019.

The Influenza Medication market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Influenza Medication market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Influenza Medication market has been segmented into
Zanamivir
Oseltamivir
Peramivir
Amantadine
Rimantadine
Inosine
Other

By Application, Influenza Medication has been segmented into:
Hospitals
Clinics
Pharmacies
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Influenza Medication market presented in the report. This section sheds light on the sales growth of different regional and country-level Influenza Medication markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Influenza Medication market.

The report offers in-depth assessment of the growth and other aspects of the Influenza Medication market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Influenza Medication Market Share Analysis
Influenza Medication competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Influenza Medication sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Influenza Medication sales, revenue and market share for each player covered in this report.

The major players covered in Influenza Medication are:
Daiichi Sankyo Company
Mylan
F. Hoffmann-La Roche
GlaxoSmithKline
Sun Pharmaceutical Industries
Natco Pharma
Sandoz International GmbH (Novartis AG)
Teva Pharmaceutical

Among other players domestic and global, Influenza Medication market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Influenza Medication product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Influenza Medication, with price, sales, revenue and global market share of Influenza Medication in 2018 and 2019.
Chapter 3, the Influenza Medication competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Influenza Medication breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Influenza Medication market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Influenza Medication sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

Table of Contents

1 Market Overview
1.1 Influenza Medication Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Influenza Medication Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Zanamivir
1.2.3 Oseltamivir
1.2.4 Peramivir
1.2.5 Amantadine
1.2.6 Rimantadine
1.2.7 Inosine
1.2.8 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Influenza Medication Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Pharmacies
1.3.5 Others
1.4 Overview of Global Influenza Medication Market
1.4.1 Global Influenza Medication Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Daiichi Sankyo Company
2.1.1 Daiichi Sankyo Company Details
2.1.2 Daiichi Sankyo Company Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Daiichi Sankyo Company SWOT Analysis
2.1.4 Daiichi Sankyo Company Product and Services
2.1.5 Daiichi Sankyo Company Influenza Medication Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Mylan
2.2.1 Mylan Details
2.2.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Mylan SWOT Analysis
2.2.4 Mylan Product and Services
2.2.5 Mylan Influenza Medication Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 F. Hoffmann-La Roche
2.3.1 F. Hoffmann-La Roche Details
2.3.2 F. Hoffmann-La Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 F. Hoffmann-La Roche SWOT Analysis
2.3.4 F. Hoffmann-La Roche Product and Services
2.3.5 F. Hoffmann-La Roche Influenza Medication Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 GlaxoSmithKline
2.4.1 GlaxoSmithKline Details
2.4.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 GlaxoSmithKline SWOT Analysis
2.4.4 GlaxoSmithKline Product and Services
2.4.5 GlaxoSmithKline Influenza Medication Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Sun Pharmaceutical Industries
2.5.1 Sun Pharmaceutical Industries Details
2.5.2 Sun Pharmaceutical Industries Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Sun Pharmaceutical Industries SWOT Analysis
2.5.4 Sun Pharmaceutical Industries Product and Services
2.5.5 Sun Pharmaceutical Industries Influenza Medication Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Natco Pharma
2.6.1 Natco Pharma Details
2.6.2 Natco Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Natco Pharma SWOT Analysis
2.6.4 Natco Pharma Product and Services
2.6.5 Natco Pharma Influenza Medication Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Sandoz International GmbH (Novartis AG)
2.7.1 Sandoz International GmbH (Novartis AG) Details
2.7.2 Sandoz International GmbH (Novartis AG) Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Sandoz International GmbH (Novartis AG) SWOT Analysis
2.7.4 Sandoz International GmbH (Novartis AG) Product and Services
2.7.5 Sandoz International GmbH (Novartis AG) Influenza Medication Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Teva Pharmaceutical
2.8.1 Teva Pharmaceutical Details
2.8.2 Teva Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Teva Pharmaceutical SWOT Analysis
2.8.4 Teva Pharmaceutical Product and Services
2.8.5 Teva Pharmaceutical Influenza Medication Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Influenza Medication Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Influenza Medication Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Influenza Medication Manufacturer Market Share in 2019
3.3.2 Top 6 Influenza Medication Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Influenza Medication Sales, Revenue and Market Share by Regions
4.1.1 Global Influenza Medication Sales and Market Share by Regions (2015-2020)
4.1.2 Global Influenza Medication Revenue and Market Share by Regions (2015-2020)
4.2 North America Influenza Medication Sales and Growth Rate (2015-2020)
4.3 Europe Influenza Medication Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Influenza Medication Sales and Growth Rate (2015-2020)
4.5 South America Influenza Medication Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Influenza Medication Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Influenza Medication Sales, Revenue and Market Share by Country
5.1.1 North America Influenza Medication Sales and Market Share by Country (2015-2020)
5.1.2 North America Influenza Medication Revenue and Market Share by Country (2015-2020)
5.2 United States Influenza Medication Sales and Growth Rate (2015-2020)
5.3 Canada Influenza Medication Sales and Growth Rate (2015-2020)
5.4 Mexico Influenza Medication Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Influenza Medication Sales, Revenue and Market Share by Country
6.1.1 Europe Influenza Medication Sales and Market Share by Country (2015-2020)
6.1.2 Europe Influenza Medication Revenue and Market Share by Country (2015-2020)
6.2 Germany Influenza Medication Sales and Growth Rate (2015-2020)
6.3 UK Influenza Medication Sales and Growth Rate (2015-2020)
6.4 France Influenza Medication Sales and Growth Rate (2015-2020)
6.5 Russia Influenza Medication Sales and Growth Rate (2015-2020)
6.6 Italy Influenza Medication Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Influenza Medication Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Influenza Medication Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Influenza Medication Revenue and Market Share by Regions (2015-2020)
7.2 China Influenza Medication Sales and Growth Rate (2015-2020)
7.3 Japan Influenza Medication Sales and Growth Rate (2015-2020)
7.4 Korea Influenza Medication Sales and Growth Rate (2015-2020)
7.5 India Influenza Medication Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Influenza Medication Sales and Growth Rate (2015-2020)
7.7 Australia Influenza Medication Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Influenza Medication Sales, Revenue and Market Share by Country
8.1.1 South America Influenza Medication Sales and Market Share by Country (2015-2020)
8.1.2 South America Influenza Medication Revenue and Market Share by Country (2015-2020)
8.2 Brazil Influenza Medication Sales and Growth Rate (2015-2020)
8.3 Argentina Influenza Medication Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Influenza Medication Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Influenza Medication Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Influenza Medication Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Influenza Medication Sales and Growth Rate (2015-2020)
9.3 Turkey Influenza Medication Sales and Growth Rate (2015-2020)
9.4 Egypt Influenza Medication Sales and Growth Rate (2015-2020)
9.5 South Africa Influenza Medication Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Influenza Medication Sales and Market Share by Type (2015-2020)
10.2 Global Influenza Medication Revenue and Market Share by Type (2015-2020)
10.3 Global Influenza Medication Price by Type (2015-2020)
11 Global Influenza Medication Market Segment by Application
11.1 Global Influenza Medication Sales Market Share by Application (2015-2020)
11.2 Global Influenza Medication Revenue Market Share by Application (2015-2020)
11.3 Global Influenza Medication Price by Application (2015-2020)
12 Market Forecast
12.1 Global Influenza Medication Sales, Revenue and Growth Rate (2021-2025)
12.2 Influenza Medication Market Forecast by Regions (2021-2025)
12.2.1 North America Influenza Medication Market Forecast (2021-2025)
12.2.2 Europe Influenza Medication Market Forecast (2021-2025)
12.2.3 Asia-Pacific Influenza Medication Market Forecast (2021-2025)
12.2.4 South America Influenza Medication Market Forecast (2021-2025)
12.2.5 Middle East & Africa Influenza Medication Market Forecast (2021-2025)
12.3 Influenza Medication Market Forecast by Type (2021-2025)
12.3.1 Global Influenza Medication Sales Forecast by Type (2021-2025)
12.3.2 Global Influenza Medication Market Share Forecast by Type (2021-2025)
12.4 Influenza Medication Market Forecast by Application (2021-2025)
12.4.1 Global Influenza Medication Sales Forecast by Application (2021-2025)
12.4.2 Global Influenza Medication Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Influenza Medication Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Influenza Medication by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Influenza Medication Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Daiichi Sankyo Company Basic Information, Manufacturing Base and Competitors
Table 8. Daiichi Sankyo Company Influenza Medication Major Business
Table 9. Daiichi Sankyo Company Influenza Medication Total Revenue (USD Million) (2018-2019)
Table 10. Daiichi Sankyo Company SWOT Analysis
Table 11. Daiichi Sankyo Company Influenza Medication Product and Services
Table 12. Daiichi Sankyo Company Influenza Medication Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Mylan Basic Information, Manufacturing Base and Competitors
Table 14. Mylan Influenza Medication Major Business
Table 15. Mylan Influenza Medication Total Revenue (USD Million) (2018-2019)
Table 16. Mylan SWOT Analysis
Table 17. Mylan Influenza Medication Product and Services
Table 18. Mylan Influenza Medication Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 20. F. Hoffmann-La Roche Influenza Medication Major Business
Table 21. F. Hoffmann-La Roche Influenza Medication Total Revenue (USD Million) (2018-2019)
Table 22. F. Hoffmann-La Roche SWOT Analysis
Table 23. F. Hoffmann-La Roche Influenza Medication Product and Services
Table 24. F. Hoffmann-La Roche Influenza Medication Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 26. GlaxoSmithKline Influenza Medication Major Business
Table 27. GlaxoSmithKline Influenza Medication Total Revenue (USD Million) (2018-2019)
Table 28. GlaxoSmithKline SWOT Analysis
Table 29. GlaxoSmithKline Influenza Medication Product and Services
Table 30. GlaxoSmithKline Influenza Medication Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 32. Sun Pharmaceutical Industries Influenza Medication Major Business
Table 33. Sun Pharmaceutical Industries Influenza Medication Total Revenue (USD Million) (2018-2019)
Table 34. Sun Pharmaceutical Industries SWOT Analysis
Table 35. Sun Pharmaceutical Industries Influenza Medication Product and Services
Table 36. Sun Pharmaceutical Industries Influenza Medication Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Natco Pharma Basic Information, Manufacturing Base and Competitors
Table 38. Natco Pharma Influenza Medication Major Business
Table 39. Natco Pharma Influenza Medication Total Revenue (USD Million) (2018-2019)
Table 40. Natco Pharma SWOT Analysis
Table 41. Natco Pharma Influenza Medication Product and Services
Table 42. Natco Pharma Influenza Medication Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Sandoz International GmbH (Novartis AG) Basic Information, Manufacturing Base and Competitors
Table 44. Sandoz International GmbH (Novartis AG) Influenza Medication Major Business
Table 45. Sandoz International GmbH (Novartis AG) Influenza Medication Total Revenue (USD Million) (2018-2019)
Table 46. Sandoz International GmbH (Novartis AG) SWOT Analysis
Table 47. Sandoz International GmbH (Novartis AG) Influenza Medication Product and Services
Table 48. Sandoz International GmbH (Novartis AG) Influenza Medication Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 50. Teva Pharmaceutical Influenza Medication Major Business
Table 51. Teva Pharmaceutical Influenza Medication Total Revenue (USD Million) (2018-2019)
Table 52. Teva Pharmaceutical SWOT Analysis
Table 53. Teva Pharmaceutical Influenza Medication Product and Services
Table 54. Teva Pharmaceutical Influenza Medication Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Global Influenza Medication Sales by Manufacturer (2018-2019) (K Units)
Table 56. Global Influenza Medication Revenue by Manufacturer (2018-2019) (USD Million)
Table 57. Global Influenza Medication Sales by Regions (2015-2020) (K Units)
Table 58. Global Influenza Medication Sales Market Share by Regions (2015-2020)
Table 59. Global Influenza Medication Revenue by Regions (2015-2020) (USD Million)
Table 60. North America Influenza Medication Sales by Countries (2015-2020) (K Units)
Table 61. North America Influenza Medication Sales Market Share by Countries (2015-2020)
Table 62. North America Influenza Medication Revenue by Countries (2015-2020) (USD Million)
Table 63. North America Influenza Medication Revenue Market Share by Countries (2015-2020)
Table 64. Europe Influenza Medication Sales by Countries (2015-2020) (K Units)
Table 65. Europe Influenza Medication Sales Market Share by Countries (2015-2020)
Table 66. Europe Influenza Medication Revenue by Countries (2015-2020) (USD Million)
Table 67. Asia-Pacific Influenza Medication Sales by Regions (2015-2020) (K Units)
Table 68. Asia-Pacific Influenza Medication Sales Market Share by Regions (2015-2020)
Table 69. Asia-Pacific Influenza Medication Revenue by Regions (2015-2020) (USD Million)
Table 70. South America Influenza Medication Sales by Countries (2015-2020) (K Units)
Table 71. South America Influenza Medication Sales Market Share by Countries (2015-2020)
Table 72. South America Influenza Medication Revenue by Countries (2015-2020) (USD Million)
Table 73. South America Influenza Medication Revenue Market Share by Countries (2015-2020)
Table 74. Middle East & Africa Influenza Medication Sales by Countries (2015-2020) (K Units)
Table 75. Middle East & Africa Influenza Medication Sales Market Share by Countries (2015-2020)
Table 76. Middle East & Africa Influenza Medication Revenue by Countries (2015-2020) (USD Million)
Table 77. Middle East & Africa Influenza Medication Revenue Market Share by Countries (2015-2020)
Table 78. Global Influenza Medication Sales by Type (2015-2020) (K Units)
Table 79. Global Influenza Medication Sales Share by Type (2015-2020)
Table 80. Global Influenza Medication Revenue by Type (2015-2020) (USD Million)
Table 81. Global Influenza Medication Revenue Share by Type (2015-2020)
Table 82. Global Influenza Medication Sales by Application (2015-2020) (K Units)
Table 83. Global Influenza Medication Sales Share by Application (2015-2020)
Table 84. Global Influenza Medication Sales Forecast by Regions (2021-2025) (K Units)
Table 85. Global Influenza Medication Market Share Forecast by Regions (2021-2025)
Table 86. Global Influenza Medication Sales Forecast by Type (2021-2025) (K Units)
Table 87. Global Influenza Medication Market Share Forecast by Type (2021-2025)
Table 88. Global Influenza Medication Sales Forecast by Application (2021-2025)
Table 89. Global Influenza Medication Market Share Forecast by Application (2021-2025)
Table 90. Direct Channel Pros & Cons
Table 91. Indirect Channel Pros & Cons
Table 92. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Influenza Medication Picture
Figure 2. Global Sales Market Share of Influenza Medication by Type in 2019
Figure 3. Zanamivir Picture
Figure 4. Oseltamivir Picture
Figure 5. Peramivir Picture
Figure 6. Amantadine Picture
Figure 7. Rimantadine Picture
Figure 8. Inosine Picture
Figure 9. Other Picture
Figure 10. Influenza Medication Sales Market Share by Application in 2018
Figure 11. Hospitals Picture
Figure 12. Clinics Picture
Figure 13. Pharmacies Picture
Figure 14. Others Picture
Figure 15. Global Influenza Medication Market Status and Outlook (2015-2025) (USD Million)
Figure 16. United States Influenza Medication Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Canada Influenza Medication Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Mexico Influenza Medication Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Germany Influenza Medication Revenue (Value) and Growth Rate (2015-2025)
Figure 20. France Influenza Medication Revenue (Value) and Growth Rate (2015-2025)
Figure 21. UK Influenza Medication Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Russia Influenza Medication Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Italy Influenza Medication Revenue (Value) and Growth Rate (2015-2025)
Figure 24. China Influenza Medication Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Japan Influenza Medication Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Korea Influenza Medication Revenue (Value) and Growth Rate (2015-2025)
Figure 27. India Influenza Medication Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Southeast Asia Influenza Medication Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Australia Influenza Medication Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 30. Brazil Influenza Medication Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Egypt Influenza Medication Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Saudi Arabia Influenza Medication Revenue (Value) and Growth Rate (2015-2025)
Figure 33. South Africa Influenza Medication Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Turkey Influenza Medication Revenue (Value) and Growth Rate (2015-2025)
Figure 35. Global Influenza Medication Sales Market Share by Manufacturer in 2019
Figure 36. Global Influenza Medication Revenue Market Share by Manufacturer in 2019
Figure 37. Top 3 Influenza Medication Manufacturer (Revenue) Market Share in 2019
Figure 38. Top 6 Influenza Medication Manufacturer (Revenue) Market Share in 2019
Figure 39. Key Manufacturer Market Share Trend
Figure 40. Global Influenza Medication Sales and Growth Rate (2015-2020) (K Units)
Figure 41. Global Influenza Medication Revenue and Growth Rate (2015-2020) (USD Million)
Figure 42. Global Influenza Medication Revenue Market Share by Regions (2015-2020)
Figure 43. Global Influenza Medication Revenue Market Share by Regions in 2018
Figure 44. North America Influenza Medication Sales and Growth Rate (2015-2020)
Figure 45. Europe Influenza Medication Sales and Growth Rate (2015-2020)
Figure 46. Asia-Pacific Influenza Medication Sales and Growth Rate (2015-2020)
Figure 47. South America Influenza Medication Sales and Growth Rate (2015-2020)
Figure 48. Middle East & Africa Influenza Medication Sales and Growth Rate (2015-2020)
Figure 49. North America Influenza Medication Revenue and Growth Rate (2015-2020) (USD Million)
Figure 50. North America Influenza Medication Sales Market Share by Countries (2015-2020)
Figure 51. North America Influenza Medication Sales Market Share by Countries in 2018
Figure 52. North America Influenza Medication Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 53. North America Influenza Medication Revenue Market Share by Countries in 2018
Figure 54. United States Influenza Medication Sales and Growth Rate (2015-2020) (K Units)
Figure 55. Canada Influenza Medication Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Mexico Influenza Medication Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Europe Influenza Medication Revenue and Growth Rate (2015-2020) (USD Million)
Figure 58. Europe Influenza Medication Revenue Market Share by Countries (2015-2020)
Figure 59. Europe Influenza Medication Revenue Market Share by Countries in 2019
Figure 60. Germany Influenza Medication Sales and Growth Rate (2015-2020) (K Units)
Figure 61. UK Influenza Medication Sales and Growth Rate (2015-2020) (K Units)
Figure 62. France Influenza Medication Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Russia Influenza Medication Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Italy Influenza Medication Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Asia-Pacific Influenza Medication Revenue and Growth Rate (2015-2020) (USD Million)
Figure 66. Asia-Pacific Influenza Medication Sales Market Share by Regions 2019
Figure 67. Asia-Pacific Influenza Medication Revenue Market Share by Regions 2019
Figure 68. China Influenza Medication Sales and Growth Rate (2015-2020) (K Units)
Figure 69. Japan Influenza Medication Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Korea Influenza Medication Sales and Growth Rate (2015-2020) (K Units)
Figure 71. India Influenza Medication Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Southeast Asia Influenza Medication Sales and Growth Rate (2015-2020) (K Units)
Figure 73. South America Influenza Medication Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. South America Influenza Medication Sales Market Share by Countries in 2019
Figure 75. South America Influenza Medication Revenue Market Share by Countries in 2019
Figure 76. Brazil Influenza Medication Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Argentina Influenza Medication Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Middle East and Africa Influenza Medication Revenue and Growth Rate (2015-2020) (USD Million)
Figure 79. Middle East and Africa Influenza Medication Sales Market Share by Countries in 2019
Figure 80. Middle East and Africa Influenza Medication Revenue Market Share by Countries (2015-2020)
Figure 81. Middle East and Africa Influenza Medication Revenue Market Share by Countries in 2019
Figure 82. Saudi Arabia Influenza Medication Sales and Growth Rate (2015-2020) (K Units)
Figure 83. Egypt Influenza Medication Sales and Growth Rate (2015-2020) (K Units)
Figure 84. Turkey Influenza Medication Sales and Growth Rate (2015-2020) (K Units)
Figure 85. South Africa Influenza Medication Sales and Growth Rate (2015-2020) (K Units)
Figure 86. Global Influenza Medication Sales and Growth Rate (2021-2025) (K Units)
Figure 87. Global Influenza Medication Revenue and Growth Rate (2021-2025) (USD Million)
Figure 88. North America Sales Influenza Medication Market Forecast (2021-2025) (K Units)
Figure 89. Europe Sales Influenza Medication Market Forecast (2021-2025) (K Units)
Figure 90. Asia-Pacific Sales Influenza Medication Market Forecast (2021-2025) (K Units)
Figure 91. South America Sales Influenza Medication Market Forecast (2021-2025) (K Units)
Figure 92. Middle East & Africa Sales Influenza Medication Market Forecast (2021-2025) (K Units)
Figure 93. Sales Channel: Direct Channel vs Indirect Channel